-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Acrivon Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2021 to 2023.
- Acrivon Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $200K, a 100% increase year-over-year.
- Acrivon Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $735K, a 65.5% increase year-over-year.
- Acrivon Therapeutics, Inc. annual Depreciation for 2023 was $536K, a 47.3% increase from 2022.
- Acrivon Therapeutics, Inc. annual Depreciation for 2022 was $364K, a 884% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)